Biocon is a leading biopharmaceutical company headquartered in Bangalore, India. Established in 1978 by Kiran Mazumdar-Shaw, Biocon primarily focuses on developing and manufacturing innovative treatments for cancer, diabetes, and other diseases. The company has a strong presence in India and is rapidly growing its global footprint. It leverages cutting-edge technology and world-class research facilities to develop biosimilars and other specialty drugs, with the aim of providing affordable healthcare to patients worldwide. Biocon is committed to enhancing access to quality healthcare and has been recognized globally for its contribution to the industry. With a mission to create a healthier world, the company continues to relentlessly pursue scientific excellence and innovation.